76 reports

Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Cervical Cancer Diagnostic Tests pipeline products with...

  • Cervical Cancer
  • United States
  • China
  • Cervical Cancer Screening Coverage
  • Drug Approval

Major players in the cervical cancer drugs market are F. Hoffmann-La Roche Ltd, Hetero, GlaxoSmithKline, Eli Lilly and Company, Pfizer, Alnylam Pharmaceuticals, Allergan plc, Biocon Limited, Bristol-Myers Squibb Company and Novartis AG. The global cervical cancer drugs market is expected to grow from $21.29 billion in 2021 to $23.23...

  • Cervical Cancer
  • World
  • Middle East
  • APAC
  • HIV AIDS Prevalence
  • Drug Approval

Cervical Cancer (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer - Drugs In Development, 2021, provides an overview of the Cervical Cancer (Oncology) pipeline landscape.Cervical cancer occurs when abnormal cells on the...

  • Cervical Cancer
  • World

Major players in the cervical cancer drugs market are F. Hoffmann-La Roche Ltd, Hetero, GlaxoSmithKline, Eli Lilly and Company, and Pfizer.The cervical cancer drugs market consists of sales of cervical cancer drugs used for the treatment of cervical cancer in women. The cervical cancer is the medical condition in which there is a tumor formation...

  • Cervical Cancer
  • World
  • Drug Approval
  • HIV AIDS Prevalence

Abstract: - Global Cervical Cancer Diagnostic Testing Market to Reach $8.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cervical Cancer Diagnostic Testing estimated at US$5.9 Billion in the year 2020, is projected to reach a revised size of US$8.2 Billion by 2027, growing at aCAGR of 4.9% over...

  • Diagnostics
  • Cervical Cancer
  • World
  • China
  • United States
  • Cervical Cancer Screening Coverage

Abstract: - Global Cervical Cancer Treatment Market to Reach $9.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cervical Cancer Treatment estimated at US$7 Billion in the year 2020, is projected to reach a revised size of US$9.8 Billion by 2027, growing at a CAGR of 4.8% over the analysis period...

  • Cancer
  • Cervical Cancer
  • World
  • China
  • United States

Cervical Cancer - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer - Pipeline Review, H2 2020, provides an overview of the Cervical Cancer (Oncology) pipeline landscape. Cervical cancer occurs when abnormal cells on the cervix...

  • Cervical Cancer
  • World

The Asia Pacific pre-lit disposable vaginal speculum market is expected to reach US$ 79.35 million by 2027 from US$ 57.80 million in 2019. The market is estimated to grow at a CAGR of 4.1% from 2020 to 2027. Key factors that are driving the market include high prevalence of cervical cancer and increase in government initiatives for cervical...

  • Healthcare
  • Cervical Cancer
  • Diagnostics
  • Ambulatory Care
  • Hospital
  • Laboratory
  • APAC
  • Cervical Cancer Screening Coverage
  • Fertility Rate

The cervical cancer diagnostic testing market is projected to reach US$ 7,165.92 million by 2028 from US$ 5,141.25 million in 2021; it is expected to grow at a CAGR of 4.9% from 2021 to 2028. Cancer has emerged as a leading cause of death across the world.According to the World Health Organization (WHO), cancer was the first leading cause...

  • Cervical Cancer
  • Diagnostics
  • World
  • APAC
  • Diagnostic Revenue
  • Cervical Cancer Screening Coverage

Major players in the cervical cancer diagnostics market are Abbott Laboratories, Becton, Dickinson and Co., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hologic Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens Healthineers AG, Zilico, and Guided Therapeutics. The global cervical cancer diagnostics market is expected to grow...

  • Cervical Cancer
  • World

Cervical Cancer Screening Market, Patients, Mortality Global Forecast by Tests Type (Pap Smear, HPV DNA, VIA), 19 Countries Analysis Globally, cervical cancer is the most appearing cancer in women. Cervical cancer is most frequently diagnosed in women between the age of 35 and 44 with the average...

  • Diagnostics
  • Hospital
  • Cervical Cancer
  • World
  • Cervical Cancer Screening Coverage
  • Cancer Mortality

Abstract: - Global Cancer Biomarkers Market to Reach $40.4 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cancer Biomarkers estimated at US$17.1 Billion in the year 2020, is projected to reach a revised size of US$40.4 Billion by 2027, growing at a CAGR of 13% over the analysis period 2020-2027....

  • Biomarker
  • Cervical Cancer
  • World
  • China
  • United States

China’s demand for Cervical Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export,...

  • Cervical Cancer
  • China
  • United States
  • Industrial Production
  • Labour Force

Cervical Cancer - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer – Pipeline Review, H1 2020, provides an overview of the Cervical Cancer (Oncology) pipeline landscape. Cervical cancer occurs when abnormal cells on the...

  • Cervical Cancer
  • World

The global colposcopes market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...

  • Endoscope
  • Cervical Cancer
  • World

Global Cervical Cancer Therapeutics Market 2020-2024 The analyst has been monitoring the global cervical cancer therapeutics market 2020-2024 and it is poised to grow by USD 1.06 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period. Our reports on global cervical cancer therapeutics market 2020-2024 provides...

  • Cervical Cancer
  • World

Market Overview The HPV testing & PAP test market is expected to witness rapid growth due to the increasing number of cervical cancer cases across the globe, an increasing number of cervical cancer screening programs and the introduction of advanced technological innovations. The increasing incidence rate of cervical...

  • HPV Testing
  • Cervical Cancer
  • APAC
  • Europe
  • Cervical Cancer Screening Coverage
  • Mortality Rate

The global vaginal specula market is anticipated to reach US$ 1,094.57 Mn in 2027 from US$ 801.78 Mn in 2018. The vaginal specula market is expected to grow with a CAGR of 3.6% from 2019-2027. Driving factors are a rise in the number of cervical cancer incidences, rising numbers of diagnostic services for women’s health. However, complications...

  • Cervical Cancer
  • Diagnostics
  • Ambulatory Care
  • Laboratory
  • Stainless Steel
  • Hospital
  • World
  • Health Expenditure
  • Cervical Cancer Screening Coverage

The global cervical cancer diagnostics market grew at a CAGR of around 7% during 2015-2020. Cervical cancer diagnostics rely on a series of advanced laboratory tests, tools and procedures to evaluate abnormal cells or strains of the human papillomavirus (HPV). They are performed by taking a sample of the tissue obtained...

  • Cervical Cancer
  • Diagnostics
  • World
  • Diagnostic Imaging Density

Cervical Cancer Diagnostics and Therapeutics Market Report Overview Cervical Cancer Diagnostics and Therapeutics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Cervical Cancer Diagnostics and Therapeutics market types and applications....

  • Therapy
  • Cervical Cancer
  • World
  • Health Provider Density

Cervical Cancer Diagnostics Global Market Report 2020-30: Covid 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global cervical cancer diagnostics market. This report focuses on cervical cancer diagnostics market which is experiencing strong growth....

  • Cervical Cancer
  • Diagnostics
  • World
  • Cervical Cancer Screening Coverage

Asia Cervical Cancer Test (Screening) Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19 Asia Cervical Cancer Test (Screening) Market will reach US$ 4.5 Billion by 2027. Cervical cancer is a type of cancer caused due to the rampant proliferation of the cell. In 2021, as per our Report...

  • Diagnostics
  • Hospital
  • Cancer Diagnostics
  • Cervical Cancer
  • Asia
  • Japan
  • APAC
  • Cervical Cancer Screening Coverage

Cervical Cancer Diagnostics Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Cervical Cancer Diagnostics market including the COVID-19 pandemic...

  • Diagnostics
  • Cervical Cancer
  • Cancer Diagnostics
  • APAC
  • Central America

Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2019 Summary Human Papillomavirus Protein E7 (E7) pipeline Target constitutes close to 44 molecules. Out of which approximately 29 molecules are developed by companies and remaining by the universities/institutes. The latest report Human...

  • Sexually Transmitted Disease
  • Cervical Cancer
  • World
  • United Kingdom
  • Pharmaceutical Registrations

Radiotherapy Devices Global Market Report 2020-30: Covid 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global radiotherapy devices market. This report focuses on radiotherapy devices market which is experiencing strong growth. The report gives a guide...

  • Ambulatory Care
  • Skin Cancer
  • Marketing Research
  • Lung Cancer
  • Breast Cancer
  • Cervical Cancer
  • Prostate Cancer
  • Infectious Disease
  • World

Cervical Cancer Diagnostics and Therapeutics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Cervical Cancer Diagnostics and Therapeutics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Cervical Cancer...

  • Cervical Cancer
  • Therapy
  • Diagnostics
  • World

This study focuses on China’s Cervical Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy....

  • Cervical Cancer
  • China
  • United States
  • Employment Costs
  • Pharmaceutical Production

This study focuses on China’s Cervical Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Cervical Cancer
  • China
  • United States
  • Labour Force
  • Industrial Production

The Europe HPV Testing and Pap Test Market would witness market growth of 33% CAGR during the forecast period (2021-2027). Cervical cancer is majorly preventable. The role of HPV in the growth of cervical cancer enables the installation of prevention techniques for cervical cancer. Primary prevention of cervical cancer is with the help...

  • Diagnostics
  • Cervical Cancer
  • HPV Testing
  • Hospital
  • Europe
  • Cervical Cancer Screening Coverage
  • Mortality Rate

About this market The increasing number of cervical cancer endoscopic device launches is one of the key factors that will trigger the market growth during the forecast period. With the rising prevalence of cervical cancer, manufacturers are focusing on developing advanced diagnostic products which can improve the efficacy...

  • Cervical Cancer
  • World